Unraveling the Mechanisms of HIV Persistence and Rebound
Unraveling the Mechanisms of HIV Persistence and Rebound
批准号:
10666563
负责人:
Thomas Hope
金额:
$154.89万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-07-15 至 2027-04-30
关键词:
AnimalsAntibodiesAntiviral ResponseAquilaAreaAutopsyBindingBiological AssayBloodBlood CellsBlood specimenCCR5 geneCD4 Positive T LymphocytesCell Differentiation processCell SeparationCellsCharacteristicsCollaborationsDataDependenceDetectionDevelopmentDisadvantagedGoalsHIVHIV InfectionsHumanImmunoPETIn VitroInfectionInterferonsInterruptionInvestigationLocationMacaca mulattaMacrophageMethodsModelingMucous MembraneMyelogenousMyeloid CellsOutcomePET/CT scanPatientsPhasePlasmaPlayPopulationPopulation DynamicsPositron-Emission TomographyPredispositionProcessProteinsResidual stateResolutionResourcesRoleSIVSamplingScanningShapesSignal TransductionSiteSkinSourceStainsStimulusT-LymphocyteTechniquesTechnologyTestingTimeTissue BanksTissuesTryptaseViralViremiaVirusVirus Replicationacute infectioncell typecritical periodgranulocytehuman tissuehumanized mousein vivoinnovationinsightlymph nodesmast cellnonhuman primatenonhuman tissuepressureresponsetext searchingtherapy designviral detectionviral rebound
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT (Overall)
The persistence of HIV infection despite long term suppression of viremia by cART constitutes the major obstacle
to HIV cure. This is unfortunately true even for patients initiated on cART during acute infection. Thus, long-term
persistent HIV reservoirs are seeded rapidly post infection, and this was confirmed in the nonhuman primate
(NHP) model of HIV. In addition, data from several groups and ours strongly suggest that residual viral replication
is ongoing despite in tissues despite full suppression of viremia by cART. Our on-going studies investigate the
“eclipse phase” of viral rebound in the NHP model after cART interruption. This “eclipse phase” is key to
understand the rebound process since the virus is spreading in tissues before viremia and it is influenced by
adaptive and innate responses as well as the host microenvironment. In our studies of early (4 days post-
infection) cART initiation, our innovative SIV-env ImmunoPET-CT guided analysis and sampling led to several
important, sometimes unexpected findings: 1) we detected SIV expansion throughout the entire host for >1 week
post cART initiation, with signal decreasing thereafter; 2) Even after 6-8 months of cART, immunoPET/CT was
sensitive enough to detect residual viral (protein) signal in tissues in spite of undetectable viremia in the blood;
3) upon ART interruption, viral signals rebounded as early as 4 days post cART interruption (ATI) but also 2
weeks before detection of virus in plasma; 4) analysis of the tissues collected at rebound through our PET-CT
guided necropsy workflow surprisingly showed that the majority of infected cells were of myeloid cells. After
extensive analysis, these cells revealed to be mast cells (MC), a predominantly tissue resident granulocytes that
we demonstrate expresses CD4 and CCR5. By teaming up with a local MC expert, we were able to demonstrate
that primary tissue MC are susceptible to HIV infection in vitro and their susceptibility and ability to support viral
replication is heavily influenced by environmental stimuli. In this PPG, we will leverage several important insights
and innovative techniques developed during our current PPG to investigate the hypothesis that MC contribute to
HIV persistence in tissues during cART and/or contribute to viral rebound upon cART interruption. Moreover, we
will clarify virus-host dynamics through phyloanatomical analysis of viral populations in tissues using tissues and
cells isolated through our innovative PET-CT guided sampling workflow. These tissues will be identified also
through the analysis of additional features of “rebound tissues” that we have recognized through our current
studies. This PPG comprises of 3 independent, although highly interconnected projects, 1 scientific NHP core
and 1 administrative core. The 3 projects will all use in different ways tissues from the NHP studies as well as
resources unique to each project and will address different although complementary questions with the ultimate
goal to dissect the mechanisms of HIV persistence and rebound.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 1: Dissecting Persistent Virus Reservoirs in Tissues
-
批准号:10460076
-
项目类别:
-
资助金额:$23.02万
-
财政年份:2022
-
负责人:Thomas Hope
-
依托单位:
Role of myeloid cells in CNS and systemic reservoirs and rebound
-
批准号:10403380
-
项目类别:
-
资助金额:$106.45万
-
财政年份:2022
-
负责人:Thomas Hope
-
依托单位:
Identification of the Initial Targets of Transmission
-
批准号:10368220
-
项目类别:
-
资助金额:$91.07万
-
财政年份:2022
-
负责人:Thomas Hope
-
依托单位:
Administrative Core
-
批准号:10460074
-
项目类别:
-
资助金额:$4.55万
-
财政年份:2022
-
负责人:Thomas Hope
-
依托单位:
Project 1: Dissecting Persistent Virus Reservoirs in Tissues
-
批准号:10666579
-
项目类别:
-
资助金额:$23.77万
-
财政年份:2022
-
负责人:Thomas Hope
-
依托单位:
Identification of the Initial Targets of Transmission
-
批准号:10610848
-
项目类别:
-
资助金额:$89.45万
-
财政年份:2022
-
负责人:Thomas Hope
-
依托单位:
Unraveling the Mechanisms of HIV Persistence and Rebound
-
批准号:10460073
-
项目类别:
-
资助金额:$151.1万
-
财政年份:2022
-
负责人:Thomas Hope
-
依托单位:
Role of myeloid cells in CNS and systemic reservoirs and rebound
-
批准号:10540816
-
项目类别:
-
资助金额:$105.57万
-
财政年份:2022
-
负责人:Thomas Hope
-
依托单位:
Administrative Core
-
批准号:10666565
-
项目类别:
-
资助金额:$6.02万
-
财政年份:2022
-
负责人:Thomas Hope
-
依托单位:
Identification of the Initial Targets of Transmission
-
批准号:10157877
-
项目类别:
-
资助金额:$78.6万
-
财政年份:2020
-
负责人:Thomas Hope
-
依托单位:
Characterizing Mucosal Changes in the FRT Leading to Increased HIV Acquisition
-
批准号:10377451
-
项目类别:
-
资助金额:$66.54万
-
财政年份:2019
-
负责人:Thomas Hope
-
依托单位:
Characterizing Mucosal Changes in the FRT Leading to Increased HIV Acquisition
-
批准号:9804613
-
项目类别:
-
资助金额:$70.75万
-
财政年份:2019
-
负责人:Thomas Hope
-
依托单位:
Characterizing Mucosal Changes in the FRT Leading to Increased HIV Acquisition
-
批准号:9903218
-
项目类别:
-
资助金额:$67.6万
-
财政年份:2019
-
负责人:Thomas Hope
-
依托单位:
Barrier integrity, microbiome and HIV target cell interactions in the human male genital tract pre and post circumcision
-
批准号:10236337
-
项目类别:
-
资助金额:$62.4万
-
财政年份:2017
-
负责人:Thomas Hope
-
依托单位:
Qualification and Harmonization of PET/MRI for Cancer Clinical Trials
-
批准号:9220600
-
项目类别:
-
资助金额:$59.76万
-
财政年份:2017
-
负责人:Thomas Hope
-
依托单位:
Qualification and Harmonization of PET/MRI for Cancer Clinical Trials
-
批准号:10379930
-
项目类别:
-
资助金额:$20.04万
-
财政年份:2017
-
负责人:Thomas Hope
-
依托单位:
Barrier integrity, microbiome and HIV target cell interactions in the human male genital tract pre and post circumcision
-
批准号:9979841
-
项目类别:
-
资助金额:$59.23万
-
财政年份:2017
-
负责人:Thomas Hope
-
依托单位:
Dissecting Early Virus Reservoirs in Tissues
-
批准号:10224632
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2017
-
负责人:Thomas Hope
-
依托单位:
Viral Pathogenesis Core
-
批准号:10155402
-
项目类别:
-
资助金额:$14.31万
-
财政年份:2015
-
负责人:Thomas Hope
-
依托单位:
Viral Pathogenesis Core
-
批准号:10621230
-
项目类别:
-
资助金额:$8.05万
-
财政年份:2015
-
负责人:Thomas Hope
-
依托单位:
海外基金